Press release
Europe to Lead the Fludeoxyglucose Radionuclide Injection market from the Front between 2020 and 2030
Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET). This injection are basically used for diagnosis of cancer and coronary artery disease. 2-deoxy-2-[18F] fluoro-D-g1ucose is the active ingredients in the fludeoxyglucose (18F) radionuclide injection and it is administered by intravenous method. As the time it is injected in the body, it increase the glucose level under pathophysiological condition. Fludeoxyglucose F-18 transport and phosphorylation which is used to assess glucose metabolism. It rapidly distributed to all organs of the body after intravenous administration. Glucose metabolism of cancer cell is reflected by Fludeoxyglucose F-18 as it accumulated under Positron Emission Tomography (PET). Optimal PET imaging is generally achieved between 30 to 40 minutes after administration by Fludeoxyglucose (18F) radionuclide injection. Depending on tumor type, stage, and location, fludeoxyglucose F-18 accumulation may be increased, normal, or decreased. Fludeoxyglucose F-18 Injection are generally stored at 25°C (77°F); excursions permitted to 15-30°C in a lead shielded container.Request to Sample report @ https://www.persistencemarketresearch.com/samples/17275
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market. Moreover improved accuracy in diagnostic and low risk associated with this injection will also responsible for the robust growth of Fludeoxyglucose (18F) Radionuclide Injection market. Rising prevalence of cancer and cardiovascular diseases will also significantly drive the growth of this market. The focus of leading market player to collaborate with local and regional player will be absolute opportunity for the growth of this Fludeoxyglucose (18F) Radionuclide Injection market. The high cost of Fludeoxyglucose (18F) Radionuclide Injection will restrain the growth of this market. The lack of availability of skilled professional in low economic countries will also hamper the growth of this market.
How the Coronavirus Threat has Taken Global Business into Uncharted Waters
The global Fludeoxyglucose (18F) Radionuclide Injection market is classified on the basis of indication and end user
Based on indication, Fludeoxyglucose (18F) Radionuclide Injection market is segmented into following:
Cancer
Coronary Artery Disease
Others
Based on end user, Fludeoxyglucose (18F) Radionuclide Injection market is segmented into following:
Hospitals
Clinics
Diagnostics Center
Fludeoxyglucose (18F) Radionuclide Injection market is expected to show significant growth over the forecast period due to increasing prevalence of cancer globally. According to World Health Organization, 14.1 Mn cases registered in 2012 of cancer globally. WHO also stated that more than 33% cancer cases are associated with smoking and chewing tobacco. The global market of Fludeoxyglucose (18F) Radionuclide Injection can be classified on the basis of indication and end-user. By indication Fludeoxyglucose (18F) Radionuclide Injection market can be classified as cancer, coronary artery disease and other. By end user Fludeoxyglucose (18F) Radionuclide Injection market is classified as hospital, clinics, and diagnostic centers. Among end user, hospitals are expected to gain maximum value share over the forecast period, and diagnostic centers are projected to grow at highest CAGR.
Request to View TOC @ https://www.persistencemarketresearch.com/toc/17275
Global Fludeoxyglucose (18F) Radionuclide Injection market is classified in five key regions viz. North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure. After North America, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.
Some of the market participants in fludeoxyglucose (18F) radionuclide infection market identified across the value chain includes ,
Zevacor Pharma, Inc.
Queen’s PET Imaging Center
LLC, Triad Isotopes, Inc.
NCM USA Bronx LLC
Spectron MRC
LLC
Petnet Solutions, Inc
Shertech Laboratories
LLC
Precision Nuclear LLC
For in-depth competitive analysis, buy now@ https://www.persistencemarketresearch.com/checkout/17275
Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe to Lead the Fludeoxyglucose Radionuclide Injection market from the Front between 2020 and 2030 here
News-ID: 2209792 • Views: …
More Releases from Persistence Market Research
Global Automotive Active Health Monitoring Systems Market Expected to Surge from …
The Automotive Active Health Monitoring Systems Market is poised for significant growth over the forecast period of 2025 to 2032. This market is projected to expand from USD 683.9 million in 2025 to USD 2,338.3 million by 2032, registering a robust CAGR of 19.20%. Automotive active health monitoring systems are designed to track the real-time status of vehicles, enabling predictive maintenance, reducing downtime, and enhancing overall vehicle safety. With growing…
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth a …
➤Overview of the Market
The global primary packaging labels market is a crucial segment of the packaging industry, enabling product identification, regulatory compliance, and brand differentiation. Primary labels are applied directly on product packaging, such as bottles, vials, boxes, and pouches, serving both functional and promotional roles. As consumer awareness of product authenticity and safety continues to rise, demand for innovative labeling solutions is expanding. Moreover, stringent regulatory frameworks in industries…
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at …
➤Overview of the Market
The shelf stable packaging market plays a critical role in extending the shelf life of food and beverages without the need for refrigeration, ensuring product safety, convenience, and affordability. These packaging solutions-spanning cartons, pouches, cans, and plastic containers-are widely used in ready-to-eat meals, dairy alternatives, sauces, soups, and beverages. Growth in the market is closely linked to evolving consumer lifestyles, increasing urbanization, and demand for long-lasting packaged…
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - …
➤Overview of the Market
The global print label market is poised for substantial expansion, driven by increasing demand across industries such as food & beverages, pharmaceuticals, cosmetics, and logistics. Labels play a crucial role in brand identity, product differentiation, and regulatory compliance. In addition to providing essential information like product ingredients, expiration dates, and barcodes, printed labels serve as key marketing tools that influence consumer purchase decisions. With the rapid rise…
More Releases for Fludeoxyglucose
Future of the Radiotheranostics Market: Strategic Analysis and Forecast to 2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Radiotheranostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the last few years, we have seen a significant expansion in the radiotheranostics market. The market value is forecasted to increase from $8.79 billion in 2024 to reach a value of $10.07 billion in 2025,…
Radiotheranostics Industry Report 2025-2034: Market Dynamics, Trends, And Foreca …
The Radiotheranostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Radiotheranostics Market Size During the Forecast Period?
In the past few years, the market size of radiotheranostics has expanded quickly. Projected growth from $8.79 billion in 2024 to $10.07 billion in 2025,…
Medical Silk Fibroin Market Outlook: Expected Market Value of USD 12.1 Billion b …
Medical Silk Fibroin Market Overview
The Medical Silk Fibroin Market was valued at USD 4.12 Bn in 2024. It is expected to reach USD 12.1 Bn by 2032, with a CAGR of 14.42% during the forecast period from 2025 to 2032.
The Medical Silk Fibroin Market is gaining momentum due to the increasing demand for biocompatible and biodegradable materials in various medical applications. Silk fibroin, derived from silkworms, is recognized for its…
Global Fludeoxyglucose 18F Radionuclide Injection Market Size & Share Analysis - …
Market Overview and Report Coverage
Fludeoxyglucose 18F Radionuclide Injection is a radioactive tracer used in positron emission tomography (PET) scans to detect and localize abnormal cellular activity within the body, particularly in cancer cells. It is a glucose analog labeled with the radionuclide fluorine-18, allowing for precise imaging of metabolic processes.
The Fludeoxyglucose 18F Radionuclide Injection Market is expected to witness significant growth in the coming years. With increasing prevalence of cancer…
Communications and Media Software Market Sluggish Growth Rate Foreseen by 2021-2 …
This Communications and Media Software market analysis looks at the global market's current state and projected expansion from 2021 to 2027. It includes a summary of marketing research methodology as well as commercial potential. In this market study, the firms' static and dynamic characteristics have been merged. This research report looks at competitive business dynamics in order to truly comprehend worldwide. Major key drivers, a market synopsis, trade volume, and…
The Fludeoxyglucose (18F) Radionuclide Injection market to go the “reverse tra …
Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET). This injection are basically used for diagnosis of cancer and coronary artery disease. 2-deoxy-2-[18F] fluoro-D-g1ucose is the active ingredients in the fludeoxyglucose (18F) radionuclide injection and it is administered by intravenous method. As the time it is injected in the body, it increase the glucose level under pathophysiological condition. Fludeoxyglucose F-18 transport…
